Senhwa Completes Enrollment of a Phase 2 Investigator Initiated Trial of Silmitasertib as Novel …

Headquartered in Taiwan, with an operational base in San Diego, California, Senhwa is well-positioned to oversee the development of its compounds.

Continue

Do you trust this headline?

Based on recent headline ratings, 89% of this readership currently trusts the local media, which has an average score of 85% regionally and is currently trending positive.

89%

Media Trust Score89%

Read All

In

City, San Diego